My Profile
Log Out
ASGE lends voice to patients and gastroenterologists in influencing regulation, legislation, and insurance and professional requirements, specifically in the field of endoscopy. ASGE is at the forefront in amplifying the GI voice to bring about real improvement in the delivery of healthcare in America.
ASGE AdvocacyPriorities
ASGE AdvocacyPositions
Take Action
Patient and provider groups are urging passage of the FY 2026 Defense Spending bill to ensure full funding for the CDMRPs, which includes the Peer Reviewed Cancer Research Programs, an important source of funding for GI-related cancer research.
ACIP voted to end universal birth-dose hepatitis B vaccination, recommending the first dose at two months for infants of hepatitis B–negative mothers. Only infants of positive or unknown-status mothers get the birth dose. ASGE joined AASLD opposing this.
ASGE urges HCSC to update its Bariatric Surgery Policy to cover Endoscopic Sleeve Gastroplasty (ESG), now a Category I CPT® procedure effective Jan 1, 2026. ESG is FDA-authorized, guideline-endorsed, and proven safe, durable, and cost-effective.
ASGE physician leaders—Gary Richter, MD and Robin Mendelsohn, MD—represented gastroenterology at the AMA House of Delegates (HOD) Interim Meeting.
A broad coalition of physician organizations, including ASGE, is urging Elevance Health to withdraw its new “Facility Administrative Policy: Use of a Nonparticipating Care Provider,” set to take effect in 11 states on January 1, 2026.
View All
Shaping policies for gastroenterologists and patient care.
Learn More
Leading regulatory reforms for better GI care.
Engage with ASGE’s grassroots campaigns.
